Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Mahmoud Abbassy; Mahmoud Abbassy; Symeon Missios; Gene H Barnett; Cathy Brewer; David M Peereboom; Manmeet Ahluwalia; Gennady Neyman; Samuel T Chao; John H Suh; Michael A Vogelbaum

doi:10.1093/NEUROS/NYX369

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Mahmoud Abbassy, Mahmoud Abbassy, Symeon Missios, Gene H Barnett, Cathy Brewer, David M Peereboom, Manmeet Ahluwalia, Gennady Neyman, Samuel T Chao, John H Suh, Michael A Vogelbaum

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neurosurgery
Volume	83
DOIs	https://doi.org/10.1093/NEUROS/NYX369
State	Published - Sep 1 2018

Disciplines

Medicine and Health Sciences
Radiology

Access to Document

10.1093/NEUROS/NYX369License: Unspecified

Cite this

@article{7a663e00e9a044088b6ef420ce0a35ce,

title = "Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.",

author = "Mahmoud Abbassy and Mahmoud Abbassy and Symeon Missios and Barnett, \{Gene H\} and Cathy Brewer and Peereboom, \{David M\} and Manmeet Ahluwalia and Gennady Neyman and Chao, \{Samuel T\} and Suh, \{John H\} and Vogelbaum, \{Michael A\}",

note = "AbstractBACKGROUND. The effectiveness of stereotactic radiosurgery (SRS) for recurrent glioblastoma (rGBM) remains uncertain. SRS has been associated with a hig",

year = "2018",

month = sep,

day = "1",

doi = "10.1093/NEUROS/NYX369",

language = "American English",

volume = "83",

journal = "Neurosurgery",

}

TY - JOUR

T1 - Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

AU - Abbassy, Mahmoud

AU - Missios, Symeon

AU - Barnett, Gene H

AU - Brewer, Cathy

AU - Peereboom, David M

AU - Ahluwalia, Manmeet

AU - Neyman, Gennady

AU - Chao, Samuel T

AU - Suh, John H

AU - Vogelbaum, Michael A

N1 - AbstractBACKGROUND. The effectiveness of stereotactic radiosurgery (SRS) for recurrent glioblastoma (rGBM) remains uncertain. SRS has been associated with a hig

PY - 2018/9/1

Y1 - 2018/9/1

UR - https://academic.oup.com/neurosurgery/article-abstract/83/3/385/3988114

U2 - 10.1093/NEUROS/NYX369

DO - 10.1093/NEUROS/NYX369

M3 - Article

VL - 83

JO - Neurosurgery

JF - Neurosurgery

ER -

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Disciplines

Access to Document

Other files and links

Cite this